|
1
|
Bathla G, Dhruba DD, Liu Y, Le NH, Soni N,
Zhang H, Mohan S, Roberts-Wolfe D, Rathore S, Sonka M, et al:
Differentiation between glioblastoma and metastatic disease on
conventional MRI imaging using 3D-convolutional neural networks:
Model development and validation. Acad Radiol. 31:2041–2049. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bonada M, Rossi LF, Carone G, Panico F,
Cofano F, Fiaschi P, Garbossa D, Di Meco F and Bianconi A: Deep
learning for MRI segmentation and molecular subtyping in
glioblastoma: Critical aspects from an emerging field.
Biomedicines. 12:18782024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang J, Liu G and Wang J: Prediction of
O6-methylguanine-DNA ethyhransferase methylation status in
glioblastoma based on deep learning. J Lanzhou Univ (Med Sci).
49:50–55. 2023.
|
|
4
|
Schaff LR and Mellinghoff IK: Glioblastoma
and other primary brain malignancies in adults: A review. JAMA.
329:574–587. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Price M, Ballard C, Benedetti J, Neff C,
Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS and Ostrom QT:
CBTRUS statistical report: Primary brain and other central nervous
system tumors diagnosed in the United States in 2017–2021. Neuro
Oncol. 26 (Suppl_6):vi1–vi85. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan P, Rich JN and Kay SA: Watching the
clock in glioblastoma. Neuro Oncol. 25:1932–1946. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deng J, Li S and Huang X: Quantitative
evaluation of the therapeutic effect of temozolomide on rat C6
glioma by spectral CT imaging. J Lanzhou Univ (Med Sci). 49:25–31.
2023.
|
|
8
|
Chelliah A, Wood DA, Canas LS, Shuaib H,
Currie S, Fatania K, Frood R, Rowland-Hill C, Thust S, Wastling SJ,
et al: Glioblastoma and radiotherapy: A multicenter AI study for
Survival Predictions from MRI (GRASP study). Neuro Oncol.
26:1138–1151. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hesse F, Low J, Cao J, Bulat F, Kreis F,
Wright AJ and Brindle KM: Deuterium MRI of serine metabolism in
mouse models of glioblastoma. Magn Reson Med. 92:1811–1821. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
In't Zandt R, Mahmutovic Persson I,
Tibiletti M, von Wachenfeldt K, Parker GJM and Olsson LE; TRISTAN
Consortium, : Contrast enhanced longitudinal changes observed in an
experimental bleomycin-induced lung fibrosis rat model by radial
DCE-MRI at 9.4T. PLoS One. 19:e03106432024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kodama N, Setoi A and Kose K: Spiral MRI
on a 9.4T vertical-bore superconducting magnet using unshielded and
self-shielded gradient coils. Magn Reson Med Sci. 17:174–183. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tripathi M, D'Souza M, Bal J, Guliani S,
Jain J, Santosh Sharma R and Mondal A: Comparision of F-18 FDG and
C-11 methionine PET/CT for demonstration of subependymal deposit in
a treated case of glioblastoma multiforme. Indian J Nucl Med.
26:91–93. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B,
Geng D and Guan Y: 18F-FDG PET/CT in immunocompetent
patients with primary central nervous system lymphoma:
Differentiation from glioblastoma and correlation with DWI. Eur J
Radiol. 104:26–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malik D: FDG PET/CT in recurrent
glioblastoma multiforme with leptomeningeal and diffuse spinal cord
metastasis. Clin Nucl Med. 46:138–139. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim SH, Lee SJ and Yu SM: Study of lipid
proton difference evaluation via 9.4T MRI analysis of fatty liver
induced by exposure to methionine and choline-deficient (MCD) diet
and high-fat diet (HFD) in an animal model. Chem Phys Lipids.
242:1051642022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pudelko L, Edwards S, Balan M, Nyqvist D,
Al-Saadi J, Dittmer J, Almlöf I, Helleday T and Bräutigam L: An
orthotopic glioblastoma animal model suitable for high-throughput
screenings. Neuro Oncol. 20:1475–1484. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hsu W, Siu IM, Pradilla G, Gokaslan ZL,
Jallo GI and Gallia GL: Animal model of intramedullary spinal cord
glioma using human glioblastoma multiforme neurospheres. J
Neurosurg Spine. 16:315–319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Underhill HR: A continuous-infusion
dynamic MRI model at 3.0 Tesla for the serial quantitative
evaluation of microvascular proliferation in an animal model of
glioblastoma multiforme. Magn Reson Med. 78:1824–1838. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bolcaen J, Descamps B, Deblaere K,
Boterberg T, Hallaert G, Van den Broecke C, Decrock E, Vral A,
Leybaert L, Vanhove C and Goethals I: MRI-guided 3D conformal arc
micro-irradiation of a F98 glioblastoma rat model using the Small
Animal Radiation Research Platform (SARRP). J Neurooncol.
120:257–266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Helthuis JHG, van der Zwan A, van Doormaal
TPC, Bleys RLAW, Harteveld AA, van der Toorn A, Brozici M,
Hendrikse J and Zwanenburg JJM: High resolution 7T and 9.4T-MRI of
human cerebral arterial casts enables accurate estimations of the
cerebrovascular morphometry. Sci Rep. 8:142352018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang H, Zhang Y, Dai C, Ru T, Li J, Chen
J, Zhang B, Zhou K, Lv P, Liu R, et al: Postmortem 9.4-T MRI for
fetuses with congenital heart defects diagnosed in the first
trimester. Front Cardiovasc Med. 8:7645872021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yun TJ, Cho HR, Choi SH, Kim H, Won JK,
Park SW, Kim JH, Sohn CH and Han MH: Antiangiogenic Effect of
bevacizumab: Application of arterial spin-labeling perfusion MR
imaging in a rat glioblastoma model. AJNR Am J Neuroradiol.
37:1650–1656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nickel A, Milford D, Fischer M, Bendszus M
and Heiland S: Effect of contrast agent dosage on longitudinal
relaxation time, signal and apparent tumor volume in glioblastoma
at 9.4T. Z Med Phys. 29:206–215. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Louis DN, Perry A, Wesseling P, Brat DJ,
Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM,
Reifenberger G, et al: The 2021 WHO classification of tumors of the
central nervous system: A summary. Neuro Oncol. 23:1231–1251. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hooper GW, Ansari S, Johnson JM and Ginat
DT: Advances in the radiological evaluation of and theranostics for
glioblastoma. Cancers (Basel). 15:41622023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Naressi A, Couturier C, Devos JM, Janssen
M, Mangeat C, de Beer R and Graveron-Demilly D: Java-based
graphical user interface for the MRUI quantitation package. Magma.
12:141–152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mandal PK: In vivo proton magnetic
resonance spectroscopic signal processing for the absolute
quantitation of brain metabolites. Eur J Radiol. 81:e653–e664.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jabłoński M, Starčuková J and Starčuk Z
Jr: Processing tracking in jMRUI software for magnetic resonance
spectra quantitation reproducibility assurance. BMC Bioinformatics.
18:562017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Provencher SW: Estimation of metabolite
concentrations from localized in vivo proton NMR spectra. Magn
Reson Med. 30:672–679. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Provencher SW: Automatic quantitation of
localized in vivo 1H spectra with LCModel. NMR Biomed. 14:260–264.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Spence AM, Muzi M, Mankoff DA, O'Sullivan
SF, Link JM, Lewellen TK, Lewellen B, Pham P, Minoshima S, Swanson
K and Krohn KA: 18F-FDG PET of gliomas at delayed intervals:
Improved distinction between tumor and normal gray matter. J Nucl
Med. 45:1653–1659. 2004.PubMed/NCBI
|
|
32
|
Jansen JF, Schöder H, Lee NY, Stambuk HE,
Wang Y, Fury MG, Patel SG, Pfister DG, Shah JP, Koutcher JA and
Shukla-Dave A: Tumor metabolism and perfusion in head and neck
squamous cell carcinoma: Pretreatment multimodality imaging with 1H
magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and
[18F]FDG-PET. Int J Radiat Oncol Biol Phys. 82:299–307. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Zhang H, Zhang H, Ouyang Y, Su R,
Yang W and Huang B: Glioblastoma and solitary brain metastasis:
Differentiation by integrating demographic-MRI and Deep-learning
radiomics signatures. J Magn Reson Imaging. 60:909–920. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsiouris S, Bougias C and Fotopoulos A:
Principles and current trends in the correlative evaluation of
glioma with advanced MRI techniques and PET. Hell J Nucl Med.
22:206–219. 2019.PubMed/NCBI
|
|
35
|
Fan H, Luo Y, Gu F, Tian B, Xiong Y, Wu G,
Nie X, Yu J, Tong J and Liao X: Artificial intelligence-based MRI
radiomics and radiogenomics in glioma. Cancer Imaging. 24:362024.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Molina D, Perez-Beteta J, Luque B, Arregui
E, Calvo M, Borras JM, Lopez C, Martino J, Velasquez C, Asenjo B,
et al: Tumour heterogeneity in glioblastoma assessed by MRI texture
analysis: A potential marker of survival. Br J Radiol.
89:201602422016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Clément A, Doyen M, Fauvelle F, Hossu G,
Chen B, Barberi-Heyob M, Hirtz A, Stupar V, Lamiral Z, Pouget C, et
al: In vivo characterization of physiological and metabolic changes
related to isocitrate dehydrogenase 1 mutation expcression by
multiparametric MRI and MRS in a rat model with orthotopically
grafted human-derived glioblastoma cell lines. NMR Biomed.
34:e44902021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kumar M, Arlauckas SP, Saksena S, Verma G,
Ittyerah R, Pickup S, Popov AV, Delikatny EJ and Poptani H:
Magnetic resonance spectroscopy for detection of choline kinase
inhibition in the treatment of brain tumors. Mol Cancer Ther.
14:899–908. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shukla G, Alexander GS, Bakas S, Nikam R,
Talekar K, Palmer JD and Shi W: Advanced magnetic resonance imaging
in glioblastoma: A review. Chin Clin Oncol. 6:402017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aleid AM, Alrasheed AS, Aldanyowi SN and
Almalki SF: Advanced magnetic resonance imaging for glioblastoma:
Oncology-radiology integration. Surg Neurol Int. 15:3092024.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Han X, Xiao K, Bai J, Li F, Cui B, Cheng
Y, Liu H and Lu J: Multimodal MRI and 1H-MRS for
preoperative stratification of high-risk molecular subtype in
adult-type diffuse gliomas. Diagnostics (Basel). 14:25692024.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang L, Chen G and Dai K: Hydrogen proton
magnetic resonance spectroscopy (MRS) in differential diagnosis of
intracranial tumors: A systematic review. Contrast Media Mol
Imaging. 2022:72421922022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wilson M, Andronesi O, Barker PB, Bartha
R, Bizzi A, Bolan PJ, Brindle KM, Choi IY, Cudalbu C, Dydak U, et
al: Methodological consensus on clinical proton MRS of the brain:
Review and recommendations. Magn Reson Med. 82:527–550. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Henning A: Proton and multinuclear
magnetic resonance spectroscopy in the human brain at ultra-high
field strength: A review. Neuroimage. 168:181–198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tran D, Nguyen DH, Nguyen HK, Nguyen-Thanh
VA, Dong-Van H and Nguyen MD: Diagnostic performance of MRI
perfusion and spectroscopy for brainstem glioma grading. Eur Rev
Med Pharmacol Sci. 26:7938–7948. 2022.PubMed/NCBI
|
|
46
|
Shi Y, Liu D, Kong Z, Liu Q, Xing H, Wang
Y, Wang Y and Ma W: Prognostic value of choline and other
metabolites measured using 1H-magnetic resonance
spectroscopy in gliomas: A meta-analysis and systemic review.
Metabolites. 12:12192022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li J, Sun J, Wang N and Zhang Y: Study on
the relationship between MRI functional imaging and multiple
immunohistochemical features of glioma: A noninvasive and more
precise glioma management. Mol Imaging. 23:153535082412615832024.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gao W, Wang X, Li F, Shi W, Li H and Zeng
Q: Cho/Cr ratio at MR spectroscopy as a biomarker for cellular
proliferation activity and prognosis in glioma: Correlation with
the expression of minichromosome maintenance protein 2. Acta
Radiol. 60:106–112. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bhaduri S, Kelly CL, Lesbats C, Sharkey J,
Ressel L, Mukherjee S, Platt MD, Delikatny EJ and Poptani H:
Metabolic changes in glioblastomas in response to choline kinase
inhibition: In vivo MRS in rodent models. NMR Biomed. 36:e48552023.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nakamura H, Doi M, Suzuki T, Yoshida Y,
Hoshikawa M, Uchida M, Tanaka Y, Takagi M and Nakajima Y: The
significance of lactate and lipid peaks for predicting primary
neuroepithelial tumor grade with proton MR spectroscopy. Magn Reson
Med Sci. 17:238–243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hnilicová P, Richterová R, Kantorová E,
Bittšanský M, Baranovičová E and Dobrota D: Proton MR spectroscopic
imaging of human glioblastomas at 1.5 Tesla. Gen Physiol Biophys.
36:531–537. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Steidl E, Pilatus U, Hattingen E,
Steinbach JP, Zanella F, Ronellenfitsch MW and Bähr O: Myoinositol
as a biomarker in recurrent glioblastoma treated with bevacizumab:
A 1H-magnetic resonance spectroscopy study. PLoS One.
11:e01681132016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zajkowska K, Cegla P and Dedecjus M: Role
of [18F]FDG PET/CT in the management of follicular
cell-derived thyroid carcinoma. Cancer Imaging. 24:1472024.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li T, Xu D, Ruan Z, Zhou J, Sun W, Rao B
and Xu H: Metabolism/immunity dual-regulation thermogels
potentiating immunotherapy of glioblastoma through
lactate-excretion inhibition and PD-1/PD-L1 blockade. Adv Sci
(Weinh). 11:e23101632024. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Patching SG: Glucose transporters at the
blood-brain barrier: Function, regulation and gateways for drug
delivery. Mol Neurobiol. 54:1046–1077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hatano T, Zhao S, Zhao Y, Nishijima K,
Kuno N, Hanzawa H, Sakamoto T, Tamaki N and Kuge Y: Biological
characteristics of intratumoral [F-18]-fluoromisonidazole
distribution in a rodent model of glioma. Int J Oncol. 42:823–830.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Stocksdale B, Nagpal S, Hixson JD, Johnson
DR, Rai P, Shivaprasad A and Tremont-Lukats IW: Neuro-oncology
practice clinical debate: Long-term antiepileptic drug prophylaxis
in patients with glioma. Neurooncol Pract. 7:583–588.
2020.PubMed/NCBI
|
|
58
|
Doblas S, He T, Saunders D, Hoyle J, Smith
N, Pye Q, Lerner M, Jensen RL and Towner RA: In vivo
characterization of several rodent glioma models by 1H MRS. NMR
Biomed. 25:685–694. 2012. View Article : Google Scholar : PubMed/NCBI
|
